TRUMENBA HELPS PROVIDE PROTECTION WHEN YOUR PATIENTS NEED IT MOST

4 REASONS TO VACCINATE WITH TRUMENBA

Trumenba is the only MenB vaccine that demonstrates coverage against diverse MenB strains by targeting both subfamilies, A and B, of fHBP

The 2-dose schedule (0,6 months) is recommended by the ACIP for healthy adolescents and young adults

ACIP recommends 3 doses (0, 1-2, 6 months) for persons aged ≥ 10 years who are at risk.

TRUMENBA is the only MenB vaccine studied concomitantly with the following adolescent vaccines: the HPV4, MCV4, and Tdap vaccines.

TRUMENBA elicited protective immune response for up to 4 years.

-The percentage of subjects with protective antibodies (hSBA titers ≥ 1:4) evaluated against 4 prevalent MenB strains declined sharply over the course of 12 months after completion of primary vaccination, then remained stable for up to 4 years

-At 4 years, the responses were similar between subjects who received a
2-dose (25%-62%) or a 3-dose (24%-61%) primary series

Please visit: www.trumenba.com to view Indication, Safety and full Prescribing Information.

ONE-STOP SHOP

Discount Vaccines & Medical/Surgical Supplies For Pediatrics, Adolescents and Adults